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SUMMARY Electrical measurements of current flow in ventricular myocardium immersed in silicone oil showed that angiotensin II increases the cell-to-cell spread of current within seconds. The increases in current spread and conduction velocity occur without any changes in resting membrane potential or maximum rate of rise of the action potential. The concentration range was 10 nM to 10 /IM, with an ED 50 of 100 DM for angiotensin exposures lasting about 10 seconds. The largest effects were an apparent decrease in resistance through the cellular pathway to 50% of control and a 40% increase in conduction velocity, which returned to control in about 15 minutes. Continuous or repeated exposure to angiotensin caused desensitization to appear. These effects were found with or without denervation by 6-hydroxydopamine and /?-adrenergic blockade by 1 JBM propranolol in calf, pig, sheep, and rabbit ventricular myocardium. Therefore, angiotensin appears to increase electrical conduction rapidly and directly in cardiac muscle by decreasing resistance through the cellular pathway. Circ Res 47: 524-529, 1980
THE EFFECT of angiotensin II on the mammalian ventricular myocardium is to increase maximum tension development (Koch-Weser, 1964) . This positive inotropic effect is direct, rather than resulting from norepinephrine release (Fowler and Holmes, 1964; Koch-Weser, 1965 angiotensin II does not induce arrhythmias, suggesting differences in the mechanism of action (Koch-Weser, 1964) . There is evidence to suggest that angiotensin II can cause increased contraction and a prolongation of the cardiac action potential by enhancement of calcium influx under certain conditions (Freer et al., 1976) . This report suggests another direct action of angiotensin (II) on cardiac muscle. It has been found (unpublished observations) that angiotensin improves the synchrony of contraction of large sheets of interconnected myocardial cells in tissue culture. The synchrony was increased by a decrease in coupling resistance that averaged 2-fold at its maximum (unpublished observations). Since this synchronizing effect of angiotensin and the measured decrease in cell-to-cell resistance were found in cultured embryonic myocardial cells, the present experiments were carried out to measure the effect of angiotensin on the electrical resistance through myocardial cells in conventional ventricular trabecular or papillary muscle strips. The silicone oil method of Weidmann (1970) was used; this method relies on the ratio of intracellular: extracellular action potential amplitudes to determine the ratio of resistances through the cellular vs. the extracellular current pathways.
Methods
These experiments were carried out on 800-1100 fim diameter ventricular trabeculae or papillary muscles from 3 calf, 4 pig, 4 sheep, 4 guinea pig, 2 rabbit, and 2 frog hearts. Calf, pig, or sheep hearts were provided by local slaughterhouses. Adult guinea pigs and rabbits were anesthetized with pentobarbital sodium (30 mg/kg ip) before removal of the heart and dissection of the papillary muscle. Frogs were pithed and decapitated before removal of the hearts. For measurement of the electrical resistance, the cylindrical muscle strips were immersed in silicone oil (5 centistoke Dow-Corning 200 fluid), and measurements were made according to the extracellular:intracellular action potential amplitude method of Weidmann (1970) (see also Wojtczak, 1979) , except that the strip ends were tied and stretched to in situ length, and stimulation of the preparations was continued at a frequency of 0.4 Hz during all measurements. By far, the most reliable preparation used was the pig right ventricular transversus trabeculum because it is often close to 1000 /tm in diameter with only <3% variation from end to end, is over 15 mm long, and excites throughout the cross-section readily. All other preparations had diameters that varied by 5-15%. The solution flow rate was 10-20 jul/min. Intracellular and extracellular recording of action potentials was carried out with fiberfilled glass microelectrodes (Murakami, quoted by Kaneko and Kater, 1973) filled with 3 M KC1 and connected to an oscilloscope through WP Instruments model 701 high input impedance, current injecting preamplifiers. Conduction velocity was measured by the time required for an action potential to propagate between two microelectrodes, the spacing of which was measured by the eyepiece micrometer of a stereomicroscope.
The composition of the isotonic solution used for mammals in these experiments was (mM/liter): 133 NaCl, 4.7 KC1, 11.9 NaHCO 3 , 1.8 CaCl 2 , 0.8 MgCl 2> 0.4 NaH 2 P0 4 , 0.03 CaNa 2 EDTA, and 7.8 glucose. Ringer's solution was used for frog hearts. All experiments were carried out at room temperature, 23-25°C. The drugs used were angiotensin 5-valine amide (angiotensin II), purchased from Sigma Chemical Company, and racemic propranolol. Denervation by 6-hydroxydopamine (6-OHDA) was done to eliminate uptake or release of norepinephrine by specific destruction of adrenergic nerve endings. We used the method of Aprigliano and Hermsmeyer (1976) except that 1 /UM propranolol was used in place of 1 HM phentolamine to decrease ^-receptor stimulation by norepinephrine released during the 6-OHDA exposure. In brief, 6-OHDA was dissolved in glutathione-buffered solution and applied for 10 minutes, with 1 hour allowed for recovery and washout of propranolol. Saralasin (P-113) was a gift from Eaton Laboratories Division of Norwich Pharmaceuticals.
All statistical comparisons were made by Student's group t-test with a confidence level of 0.05 as the criterion for a significant difference.
Results
Time Course of the Improved Conduction
In each of the mammalian species examined except guinea pig, angiotensin II improved the conduction between cells, as indicated by an increase of the ratio of the extracellular to intracellular action potential hearts amplitudes (AP 0 /APi) and by an increase in conduction velocity (6). Guinea pig hearts appeared insensitive to angiotensin II at up to 100 /XM. Figure 1 shows the action of 100 nM VOL. 47, No. 4, OCTOBER 1980 angiotensin II, a midrange dose, on the two parameters in 6-OHDA denervated calf ventricular myocardium. The decrease in the resistance through the cellular pathway (r 0 is inferred from the increased extracellular: intracellular ratio of action potential amplitudes (AP o /APi) and supported by an increased 6. The maximum decrease in the cellular resistance pathway accounting for the observed r o /ri increase would be approximately 50%. No other change in resting E m or action potential parameters, including maximum rate of rise, was detected. The onset of angiotensin II action occurred within 15 seconds, and the time to complete recovery was approximately 15 minutes. In this and similar experiments, angiotensin was applied as a 5
,1 pulse at the concentration specified, which flowed over the muscle strip in about 10 seconds. The increase in 0 occurred with the same time course, consistent with the expectation that conduction velocity should reflect the effective cellular resistance pathway.
Angiotensin II Dose-Response Curve
The effect of angiotensin II on the cellular resistance pathway was dose-dependent in the sub-micromolar range of concentrations. Figure 2 shows that the increased r o /ri and 6 were detected at concentrations as low as 10~8 M and that the ascending part of the dose-response curve is between 1 nM and 1 JUM. The average maximum decrease in x\ was 41% and the largest decrease was 58%. The values plotted here are the maximum change in r o / ri that occurred during the course of the angiotensin effect. All of the calf, sheep, pig, and rabbit preparations (13) examined showed this action of angiotensin on the r o /ri and 6.
Bundle Resistivity Decrease by Angiotensin II
An independent measure of resistance through the cells is available in the silicone oil chamber in the form of total length resistivity (ri). If the resistance of the extracellular fluid were constant and the resistance through the cells decreased, then resistivity of the muscle bundle must also decrease. From the gradient of voltage ±0.5 mm from the center of the preparation, the current, and the crosssectional area, specific resistivity (Ri) can be calculated. Table 1 shows that Ri decreased significantly during the peak angiotensin II effect. The fractional decrease in resistance is much less than in Figures 1 and 2 because the lower resistance of the unchanging extracellular pathway predominantly determines measured ri. The true decrease in specific resistivity through the cells (Ri) also can be calculated using the r o /ri ratio, as also shown in Table 1 , to be about 55% in the three experiments included. Resistivity of the extracellular fluid (R o ) is also included to show the consistency of the data and as a check on the assumptions (see Discussion). 
Separation of the Norepinephrine Effect
To determine the degree to which the well-known norepinephrine-releasing effect of angiotensin II could contribute to increases in r o /ri and 6, separate experiments were carried out without in vitro denervation or yS-adrenergic receptor blockade. The results were the same as in the concentration-response curve shown in Figure 2 , or in the time course shown in Figure 1 . However, with adrenergic nerve endings present, there was a measurable small, but significant, lengthening of the total action potential duration (from 480 to 510 msec). In the experiments reported in Figures 1 and 2 , when angiotensin was added with adrenergic influences removed, there was no change in the action potential duration. The indirect angiotensin effect (of norepinephrine released from adrenergic nerve endings) can thus be separated from the direct effect (of a decrease in the cellular resistance pathway). Ri and Ri are significantly different at P < 0.05 confidence level by group t comparison. Calculations are based on assumed extracellular space (f^s) of 25% and thickness of the aqueous fluid layer around the bundle of 20 /un. Calculations were based on the following measurements and equations: Measurements: (1) rj unnormalized resistivity (AV/Ax)/I o ; (2) 0 tot ai diameter of the muscle strip with aqueous layer; (3) 0,iri P diameter of the muscle strip without aqueous layer; (4) AP o /APi ratio of extracellular:intracellular action potential amplitude (for Ri and Ro calculations only).
Calculations: (1) Atouu = w(0 to tai/2) 2 total cross-sectional area; (2) Aceik = 7r(0 s . rip /2) 2 (1 -f ecs ); (3) A aq u e o US = A tota i -Ac^ (4) ri unnormalized resistivity of the cellular pathway; ri = n(l + xj r o ); (5) To unnormalized resistivity of the noncellular (aqueous) pathway; r o = r,(l + r o / ri ); (6) R, = r,A tM ai; (7) Ri = riA ce u.,; (8) Ro
Species Differences
In contrast to the action of angiotensin II on the other mammalian species studied, there was no effect of angiotensin II in concentrations from 1 nM to 100 JUM on guinea pig ventricular myocardium (four experiments). There was also no effect on frog ventricle. The ratio AP o /APi did not change significantly during either a brief exposure to angiotensin II or a prolonged suffusion for 30 minutes. In each case APo/APi and 6 were monitored for at least 45 minutes after the addition of angiotensin II. Similarly, no action of angiotensin II on the resting membrane potential, the rate of rise of the action potential, the action potential duration, or any other membrane parameter could be detected in guinea pig or frog ventricular myocardium.
Desensitization to Angiotensin
In addition to the method of pulse application of angiotensin II used in all of the experiments reported in Figures 1 and 2 , angiotensin II was applied to ventricular myocardium by a continuous suffusion at a constant concentration. With the suffusion method of application, a desensitization to angiotensin II could be observed in all of the angiotensinsensitive species. At concentrations above the 30 nM ED50 of the dose-response curve shown in Figure  2 , the desensitization resulted in loss of the entire r o /ri and 6 increases. The time course of one such continuous suffusion in 30 nM angiotensin II is shown in Figure 3 . The peak effect on r o /ri and 6 occurred within the first 6-8 minutes. With continuous angiotensin II suffusion rather than 10-second pulse exposure, the increases in r o /ri and 6 were prolonged for at least 10 minutes. However, during the period between 8 and 15 minutes, there was a decrease in r o /ri and 6 despite the continued suffusion of the cells with a constant angiotensin II concentration. The fall in r o /r; and 6 progressed during the next 30 minutes to the point of being less than control. At higher concentrations of angiotensin, the loss of angiotensin sensitivity began earlier and could even limit the peak effect recorded. It is possible that a peak effect did occur but was not detected in the experimental apparatus used in these experiments, which would have a time resolution of no less than 10 seconds. The highest angiotensin concentration for which desensitization did not occur was 10 nM.
Block by Saralasin
When trabeculae were treated by the angiotensin blocking agent, saralasin (1 JUM), the actions of <300 VOL. 47, No. 4, OCTOBER 1980 mi angiotensin II were completely blocked. No change in the ratio of action potential amplitudes or 0 could be detected either on addition of saralasin or exposure to angiotensin II after saralasin, although angiotensin II caused r o /ri and 0 increases in the same preparations before saralasin.
Discussion
These experiments demonstrate for the first time that angiotensin causes an increase in electrical coupling among myocardial cells with a resulting increase in conduction velocity (0). The increased coupling is inferred from an increase in amplitude of the extracellular action potential measured in a thin extracellular aqueous layer produced by silicone oil, which is taken to represent a decrease in resistance through the cellular pathway for current flow while extracellular resistance remains constant (Weidmann, 1970) , and from a measured resistivity decrease. These observations thus extend to certain adult animal hearts the generality of the observation of angiotensin synchronizing cultured myocardial cells by decreasing their junctional resistance (unpublished observations). Although it is only in the 2-cell situation that the resistance between cells, and changes in it, can be measured directly (unpublished observations), the present data support the hypothesis that angiotensin directly acts on cell-tocell coupling. The action of angiotensin on ventricular myocardium from several mammals occurred in the same range of angiotensin concentrations that previously had been demonstrated to cause a positive inotropic effect (Koch-Weser, 1964; Bonnardeaux and Regoli, 1974) . It might be expected that this coupling effect of angiotensin would occur simultaneously with the positive inotropic effect, although no contribution of increased 0 to ventricular contraction would be expected unless 0 were severely slowed.
This action of angiotensin to increase the electrical coupling between myocardial cells is unique because angiotensin is the only agent thus far reported to cause an increase in electrical coupling between myocardial cells. However, other factors decrease coupling between myocardial cells (ouabain, Weingart, 1977; ischemia, Wojtczak, 1979) . The measurement of Ri shows directly that resistance decreased in the longitudinal axis of the bundle. Ri was higher, but R o was very close to the respective values (470 and 51 Q, cm) reported by Weidmann (1970) . The increases in AP O /AP; and 0 without a change in action potential rate of rise also suggest that resistance through the cellular pathway decreased. The time course of the increase in 0, as well as its magnitude, predicted to increase by the same factor as the decrease in Vr; + r o , is totally consistent with a coupling resistance decrease. For example, in Figure 1 , the change of r o /ri from 0.13 to 0.27 would predict 0 should increase from 30 to 41 cm/sec, within error of that observed. Based on the complete electrical measurements possible on isolated pairs of cells, the fundamental mechanism is the decrease in electrical resistance between cells (unpublished observations). The time course and magnitude of the increased coupling reported here are similar to those of the coupling resistance decrease directly measured in cultured cells, making it likely that the angiotensin mechanism of action is the same in both preparations, directly on the cell coupling.
The effects of angiotensin on cardiac muscle show a species dependence that is consistent with previous reports of angiotensin effects on isolated ventricular myocardium. No effect on guinea pig ventricle was found here, as was also true of partially depolarized guinea pig cardiac muscle (Freer et al., 1976) . Furthermore, there was no effect of angiotensin on the frog ventricle, which is consistent with other reports that polypeptides exert no direct action on the frog ventricular myocardium .
The time course of action of angiotensin seen in the pulse application experiments may be reasonably similar to that in the intact circulation. AlMerani et al. (1978) have recently reported the halftime for angiotensin in the rat arterial circulation is approximately 15-16 seconds. An exposure of the myocardial cells to angiotensin for approximately 10-30 seconds could trigger a 2-to 5-minute increase in the effective conduction within the heart, as shown by Figure 1 .
The action of angiotensin is distinct from that of norepinephrine or epinephrine. The possibility that increases in r o /ri or 0 could be indirect angiotensin effects mediated through release of norepinephrine from adrenergic nerve endings (Bonaccorsi et al., 1977) thus can be eliminated. Furthermore, angiotensin effects did not include changes in action potential duration known to occur with norepinephrine (Pappano, 1971) . In fact, catecholamines are known to have a dysrhythmogenic action which often involves formation of ectopic foci (KochWeser, 1964; Geesbrecht and Randall, 1971; Davis, 1975) , which is opposite to the angiotensin effects in these experiments. The conduction-improving mechanism by which angiotensin appears to act might be an efficient way of improving depressed cardiac contractility associated with slow conduction because it would require no increase in the force produced by each myocardial cell; ergo, the myocardium would function more efficiently. The improvement of conduction by blood perfusion, without changes in resting E m or action potential rate of rise, that are previously unexplained (Rosen et al., 1972 ) may have been due to angiotensin in the perfusion blood.
With the recent demonstration that angiotensin I is converted to angiotensin II in the myocardium by converting enzyme (Cornish et al., 1979) , it appears possible that this angiotensin action may be of physiological significance under conditions in which renin release may be expected. Such a mech-anism would allow for a transient increase in the contraction efficiency of a hypodynamic myocardium while conserving metabolic reserves.
